Anti-Cancer Agents in Medicinal Chemistry

(Formerly Current Medicinal Chemistry - Anti-Cancer Agents)


Simone Carradori
Department of Pharmacy
“G. d’Annunzio” University of Chieti-Pescara

Personal Subscription
Become EABM
Become Reviewer
Call for Editor
Volume: 9 Issue: 3, March

Synthesis of Quinazolines as Tyrosine Kinase Inhibitors

Volume:9   Issue: 3
Pp: 246-275
Sanjay K. Srivastava, Vivek Kumar, Shiv K. Agarwal, Rama Mukherjee and Anand C. Burman
DOI: 10.2174/1871520610909030246
Published on: 01 March, 2012

A Trojan Horse in Drug Development: Targeting of Thapsigargins Towards Prostate Cancer Cells

Volume:9   Issue: 3
Pp: 276-294
S. Brogger Christensen, Dorthe Mondrup Skytte, Samuel R. Denmeade, Craig Dionne, Jesper Vuust Moller, Poul Nissen and John T. Isaacs
DOI: 10.2174/1871520610909030276
Published on: 01 March, 2012

Quantification Techniques and Biodistribution of Semiconductor Quantum Dots

Volume:9   Issue: 3
Pp: 295-303
Emilie Pic, Lina Bezdetnaya, Francois Guillemin and Frederic Marchal
DOI: 10.2174/1871520610909030295
Published on: 01 March, 2012

Novel Analogues of CC-1065 and the Duocarmycins for the Use in Targeted Tumour Therapies

Volume:9   Issue: 3
Pp: 304-325
Lutz F. Tietze and Birgit Krewer
DOI: 10.2174/1871520610909030304
Published on: 01 March, 2012

Antimitotic Chalcones and Related Compounds as Inhibitors of Tubulin Assembly

Volume:9   Issue: 3
Pp: 336-347
Sylvie Ducki
DOI: 10.2174/1871520610909030336
Published on: 01 March, 2012

Mechanisms of Trastuzumab Resistance in Breast Cancer

Volume:9   Issue: 3
Pp: 348-355
Sara M. Tolaney and Ian E. Krop
DOI: 10.2174/1871520610909030348
Published on: 01 March, 2012

Current Development of Pd(II) Complexes as Potential Antitumor Agents

Volume:9   Issue: 3
Pp: 356-368
Enjun Gao, Cong Liu, Mingchang Zhu, Huakuan Lin, Qiong Wu and Lei Liu
DOI: 10.2174/1871520610909030356
Published on: 01 March, 2012